Ann Tan
- Co-authors
- Richard D. KimFederico AucejoLisa RybickiBassel F. El‐RayesPaul ElsonRichard KimGalal El‐GazzazRamon M. Esclamado
- Topics
- Hepatocellular Carcinoma Treatment and Prognosis (5 papers)Renal cell carcinoma treatment (4 papers)Angiogenesis and VEGF in Cancer (4 papers)
- Journals
- Journal of Clinical OncologySHILAP Revista de lepidopterologíaCancer
- Partner nations
- United StatesCanadaAustralia
In The Last Decade
Ann Tan
15 papers receiving 232 citations
Peers
Comparison fields: 5 of 42
- Oncology 98
- Surgery 95
- Hepatology 70
- Pulmonary and Respiratory Medicine 61
- Epidemiology 53
Countries citing papers authored by Ann Tan
This map shows the geographic impact of Ann Tan's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ann Tan with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ann Tan more than expected).
Fields of papers citing papers by Ann Tan
This network shows the impact of papers produced by Ann Tan. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ann Tan. The network helps show where Ann Tan may publish in the future.
Co-authorship network of co-authors of Ann Tan
This figure shows the co-authorship network connecting the top 25 collaborators of Ann Tan. A scholar is included among the top collaborators of Ann Tan based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ann Tan. Ann Tan is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 1 | |
| 2 | 1 | |
| 3 | 18 | |
| 4 | 32 | |
| 5 | Serum vascular endothelial growth factor level in patients with hepatocellular carcinoma undergoing liver transplantation: experience of a single Western center. | 2 |
| 6 | Serum Vascular Endothelial Growth Factor Level in Patients with Hepatocellular Carcinoma Undergoing Liver Transplantation: Experience of a Single Western Center | 2 |
| 7 | 41 | |
| 8 | 13 | |
| 9 | 39 | |
| 10 | 19 | |
| 11 | 0 | |
| 12 | Adjuvant treatment after orthotopic liver transplantation: is it really necessary? | 4 |
| 13 | 3 | |
| 14 | 1 | |
| 15 | 3 | |
| 16 | 56 |
About Ann Tan
Ann Tan is a scholar working on Hepatology, Otorhinolaryngology and Cancer Research, having authored 16 papers that have together received 235 indexed citations. Recurring topics across this work include Hepatocellular Carcinoma Treatment and Prognosis (5 papers), Renal cell carcinoma treatment (4 papers) and Angiogenesis and VEGF in Cancer (4 papers). The work is most often cited by research in Otorhinolaryngology (50 citations), Hepatology (70 citations) and Oncology (98 citations). Ann Tan has collaborated with scholars based in United States, Canada and Australia. Frequent co-authors include Richard D. Kim, Federico Aucejo, Lisa Rybicki, Bassel F. El‐Rayes, Paul Elson, Richard Kim, Galal El‐Gazzaz, Ramon M. Esclamado, Michael Byrne and David J. Adelstein. Their work appears in journals such as Journal of Clinical Oncology, SHILAP Revista de lepidopterología and Cancer.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.